Abstract

The present disclosure relates to crystalline form of 4[6-(diethylaminomethyl) naphthalen-2-yl] methyl[4(hydroxycarbamoyl) phenyl] carbamate, is represented by following structural formula (I) and its process for the preparation thereof.

Formula (I)

The present disclosure further relates to use of [6-(diethylaminomethyl) naphthalen-2-yl] methyl[4(hydroxycarbamoyl) phenyl] carbamate of Formula (I) for the preparation of [6-(diethylaminomethyl) naphthalen-2-yl] methyl[4(hydroxycarbamoyl) phenyl] carbamate hydrochloride monohydrate, is represented by following structural formula (II).

Formula (II)

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS